ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,703Medicare Part D Prescriptions Filled, Including Refills

Rank: 39 out of 1877

$690K Total Retail Price of All Prescriptions

Rank: 41 out of 1877

647 Patients Receiving at Least One Drug in Part D
75% Patients 65 Years and Older
51% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Wisconsin
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

5% of this provider’s 647 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

13% of this provider’s 647 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 19%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Wisconsin
SIMVASTATIN 513 427 118 1 1
LISINOPRIL 501 385 113 2 3
OMEPRAZOLE 490 412 94 3 4
AMLODIPINE BESYLATE 434 396 92 4 6
LEVOTHYROXINE SODIUM 415 302 77 5 2
HYDROCHLOROTHIAZIDE 407 354 90 6 9
WARFARIN SODIUM 397 342 58 7 7
HYDROCODONE-ACETAMINOPHEN 331 228 80 S3 8 11
METOPROLOL SUCCINATE 313 265 61 9 14
ATENOLOL 312 254 70 10 13
FUROSEMIDE 289 238 54 11 5
METOPROLOL TARTRATE 288 271 54 12 10
ATORVASTATIN CALCIUM 247 203 54 13 8
POTASSIUM CHLORIDE 211 175 41 14 15
ENALAPRIL MALEATE 206 164 43 15 50
LORAZEPAM 173 137 36 B 16 24
TRAMADOL HCL 171 95 36 17 21
METFORMIN HCL 157 116 37 18 12
TAMSULOSIN HCL 130 115 23 19 26
SERTRALINE HCL 122 104 23 20 19
NAMENDA 117 117 12 21 31
PRAVASTATIN SODIUM 111 89 26 22 18
CRESTOR 103 82 21 23 39
ISOSORBIDE MONONITRATE ER 98 76 20 24 73
GABAPENTIN 97 67 17 25 17
LOSARTAN POTASSIUM 96 85 30 26 16
FLUOXETINE HCL 93 46 20 27 41
PROAIR HFA 92 50 32 28 44
TRAZODONE HCL 90 59 30 29 42
LOVASTATIN 88 76 18 30 29
CLOPIDOGREL 87 74 19 31 25
GLIPIZIDE ER 86 64 20 32 91
DONEPEZIL HCL 82 82 17 33 30
CITALOPRAM HBR 81 45 14 34 20
RANITIDINE HCL 77 50 17 35 33
METFORMIN HCL ER 76 59 18 36 46
JANUVIA 72 36 11 37 78
IPRATROPIUM-ALBUTEROL 72 <11 <11 37 98
ALLOPURINOL 69 55 21 39 22
ISOSORBIDE DINITRATE 69 <11 <11 39 253
MIRTAZAPINE 69 53 12 39 45
PREDNISONE 67 56 28 42 36
ADVAIR DISKUS 64 53 16 43 38
DIOVAN 64 59* 15 43 60
VENLAFAXINE HCL ER 63 50 13 45 70
NOVOLOG 63 <11 <11 45 124
LANTUS 61 <11 <11 47 61
FAMOTIDINE* 61 56* 11 47 101
CLONAZEPAM 60 55* 13 B 49 47
LANTUS SOLOSTAR 59 54* 13 50 56
MONTELUKAST SODIUM 59 <11 <11 50 65
GEMFIBROZIL 59 43 11 50 89
ALENDRONATE SODIUM 59 54* 12 50 27
ZOLPIDEM TARTRATE 57 36 15 54 32
CYCLOBENZAPRINE HCL 55 17 14 R 55 77
TRIAMCINOLONE ACETONIDE 54 42 21 56 93
NITROSTAT 54 30 35 56 266
FLUTICASONE PROPIONATE 54 49* 22 56 37
IBUPROFEN 53 21 15 59 122
GLIMEPIRIDE 52 47* 12 60 48
PANTOPRAZOLE SODIUM 52 38 14 60 34
ALPRAZOLAM 50 <11 <11 B 62 28
PIOGLITAZONE HCL 50 <11 <11 R 62 79
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 23, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.